Skip to content
Axe Capital logo Axe Capital Trading News

Astera Labs vs. Arm: Which Semiconductor Stock Is a Better Buy in 2026?

2026-10-04 15:07 •Sara Appino •The Motley Fool Positive Axe Cap view: Selective •Equities•Earnings•Geopolitics•Technology•AI•Semiconductors •ALAB•ARM•AVGO•MRVL•TSM

Axe Cap view

Astera Labs and Arm: Growth vs. Stability in Semiconductors

Astera Labs shows explosive growth but with risks; Arm offers steady returns backed by a proven business model.

Astera Labs is riding the AI wave with more than doubling its revenue in a year, impressive margins, and clear relevance in fast-growing AI infrastructure. Yet, the stock isn’t for the fainthearted—customer concentration is a real risk. One major client pulling away could dent its outlook severely. Arm, on the other hand, grows more moderately but with a well-established licensing model that generates consistent royalties. This stability comes at a premium, and its higher valuation means less room for error or disruption. For South African investors, neither name trades locally, so the rand’s movement against the dollar (USD/ZAR) can influence the investment's returns. With the Rand volatile, a strong dollar could eat into profits, especially for Astera Labs with its high growth expectations priced in USD. I would lean towards Astera Labs for those chasing growth, but keep a close eye on emerging client risks and Rand volatility. If you prefer steadier income and less FX sensitivity, Arm’s durability is worth considering. this is just our opinion and not financial advice

How I would invest

Buy Astera Labs for high growth exposure but position size carefully to manage customer and FX risks; consider trimming or holding Arm for steadier returns with less volatility.

What I would watch
  • Astera Labs (ALAB)
  • Arm (ARM)
  • USD/ZAR
What could go wrong
  • Customer concentration risk at Astera Labs
  • USD/ZAR volatility impacting returns
How strongly I feel

6/10

The article compares two semiconductor stocks: Astera Labs, which provides AI connectivity solutions with explosive 115% revenue growth but faces customer concentration risk, and Arm, which licenses chip architecture with stable 22.8% growth and reliable royalty streams. The author recommends Astera Labs for growth-focused investors despite concentration risks, while Arm suits those preferring consistency.

Our take is based on reporting first published by The Motley Fool.

Read the original story